CB
ABBV icon

Centennial Bank’s AbbVie ABBV Stock Holding History

Centennial Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$322K Sell
1,481
-170
-10% -$37.7K 0.12% 120
2025
Q4 		$377K Hold
1,651
– – 0.15% 112
2025
Q3 		$382K Hold
1,651
– – 0.15% 107
2025
Q2 		$306K Buy
1,651
+79
+5% +$14.7K 0.13% 117
2025
Q1 		$329K Sell
1,572
-75
-5% -$14.6K 0.16% 106
2024
Q4 		$293K Hold
1,647
– – 0.14% 110
2024
Q3 		$325K Sell
1,647
-39
-2% -$7.28K 0.15% 106
2024
Q2 		$289K Sell
1,686
-6
-0.4% -$994 0.14% 103
2024
Q1 		$308K Hold
1,692
– – 0.16% 106
2023
Q4 		$262K Buy
1,692
+107
+7% +$15.6K 0.16% 104
2023
Q3 		$236K Buy
1,585
+235
+17% +$34.5K 0.16% 110
2023
Q2 		$182K Sell
1,350
-870
-39% -$128K 0.12% 128
2023
Q1 		$354K Hold
2,220
– – 0.23% 101
2022
Q4 		$359K Buy
+2,220
New +$340K 0.21% 106

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Centennial Bank's ABBV Position: Q1 2026 in Review

Centennial Bank reduced its AbbVie (ABBV) stake by 10% in Q1 2026, selling an estimated $37.7K and leaving 1,481 shares worth $322K. The position accounts for 0.12% of the portfolio, ranked #120.

Centennial Bank first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $382K in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Centennial Bank held 1,481 shares of AbbVie worth $322K as of Q1 2026.
  • Centennial Bank sold 170 AbbVie shares in Q1 2026, an estimated $37.7K.
  • AbbVie made up 0.12% of Centennial Bank's portfolio in Q1 2026, its #120 holding.
  • Centennial Bank first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • Centennial Bank's AbbVie position peaked at $382K in Q3 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.